Dr. Iya Khalil, GNS chief commercial officer and co-founder, gave her perspectives on the application of machine learning to clinical trials in “Partnering in the Digital Era“, an article published by Roche this week. The precision medicine piece focuses on how collaborations between healthcare and technology companies are driving the future of healthcare and features viewpoints from inside Roche including Gregg Talbert, Global Head of Digital and Personalised Healthcare Partnering, and Michele Pedrocchi, Head of Global Strategy and Business Development for Roche Diagnostics.
Earlier this year, GNS Healthcare announced a collaboration with Genentech, a member of the Roche Group to leverage the REFS™ (Reverse Engineering and Forward Simulation) causal learning and simulation platform to power the development of novel cancer therapies.
Read the full article on Roche’s website here.